openPR Logo
Press release

European Anticoagulants Market Share 2021: Trends, Key Players, Industry Analysis and Report 2021-2027

10-23-2021 10:05 AM CET | Health & Medicine

Press release from: Orion Market Research

European anticoagulants market is estimated to grow at a CAGR of 6.6% during the forecast period. A significant rise in the demand for NOACs has been reported in the region, which in turn, is accelerating the market growth. The use of novel oral anticoagulants (NOACs) is growing significantly in Europe as their advantages over older drugs including warfarin. NOACs have demonstrated tremendous safety and efficacy without the requirement of subsequent dose adjustment and frequent monitoring. The three NOACs that are available in the EU market include Factor Xa inhibitors Xarelto (rivaroxaban) from Bayer, Boehringer Ingelheim’s thrombin inhibitor Pradaxa (dabigatran), and Pfizer/Bristol-Myers Squibb’s Eliquis (apixaban).

A full report of European Anticoagulants Market is available at: https://www.omrglobal.com/industry-reports/european-anticoagulants-market

These NOACs have practical benefits over vitamin k antagonists as they do not need monitoring and complex dose titration and have fewer interactions with food and other drugs. Some common factors that encourage patients to move from vitamin K antagonists to NOACs comprise mobility problems. Vitamin K antagonists require increased visits required as well as complaints regarding dose adjustments and discomfort including pain or bruising. The interest of Daiichi Sankyo interest in the field is focused on a Factor Xa antagonist referred to as Lixiana (edoxaban). It is available on the market in Japan, Europe, and the US.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/european-anticoagulants-market

Scope of the European Anticoagulants Market

Market Coverage

• Market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and Application
• Regions Covered- UK, Germany, France, Spain, Italy, and Rest of Europe
• Competitive Landscape- Johnson & Johnson Services, Inc., Bristol Myers Squibb Co., Pfizer Inc., Daiichi Sankyo Co. Ltd., and Boehringer Ingelheim GmbH

Recent Strategic Initiatives in the European Anticoagulants Market

• In July 2020, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended a generic version of apixaban, an anticoagulant medicine. In the meantime, the US FDA approved a generic version of chlorzoxazone, a muscle relaxant. Apixaban is an anticoagulant that is used for the treatment and prevention of blood clots and prevention of stroke. In 2011, it was first approved for use in the EU and is sold with the brand name Eliquis by Pfizer/Bristol-Myers Squibb.
• In November 2020, Boehringer Ingelheim declared the European Medicines Agency’s (EMA) Committee has adopted a positive opinion for Pradaxa (dabigatran etexilate) to treat venous thromboembolic events (VTE) and prevention of recurrent VTE in pediatric patients from birth to less than 18 years of age.

Key questions addressed by the report

• What is the market growth rate?
• Which segment/country dominates the market in the base year?
• Which segment/country will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19forecast
o Most affected segment/country
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

European Anticoagulants Market-Segmentation

By Type

• Novel Oral Anticoagulants (NOACs)
• Vitamin K Antagonist
• Heparin and Low Molecular Weight Heparin (LMWH)
By Application
• Pulmonary Embolism
• Atrial Fibrillation/Myocardial Infarction (Heart Attack)
• Deep Vein Thrombosis (DVT)
• Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-anticoagulants-market

European Anticoagulants Market– Segment by Country

• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Company Profiles

• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• Bristol Myers Squibb Co.
• Daiichi Sankyo Company, Ltd.
• GlaxoSmithKline plc
• Mylan N.V.
• Novartis International AG
• Pfizer Inc.
• Sanofi S.A.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release European Anticoagulants Market Share 2021: Trends, Key Players, Industry Analysis and Report 2021-2027 here

News-ID: 2438960 • Views: 193

More Releases from Orion Market Research

UK Cardiovascular Devices Market Trends, Research Report, Growth, Opportunities, …
UK cardiovascular devices market is projected to grow at a significant CAGR of 5.0% during the forecast period. A significant prevalence of CVD in UK and the well-developed healthcare infrastructure are augmenting the demand for cardiovascular devices market. According to the British Heart Foundation, more than one-fourth of the fatalities in the UK occur due to CVD, and it is responsible for around 1.6 million fatalities each year. Moreover, more
Indian Cardiovascular Devices Market: Analysis Report, Share, Trends and Overvie …
Indian cardiovascular devices market is projected to grow at a significant CAGR of 7.2% during the forecast period. Government is actively focused on improving healthcare infrastructure in the country due to growing number of chronic diseases including cardiovascular diseases, cancer, Alzheimer’s and others. For instance, Indian government has launched Ayushman Bharat, world’s largest government funded scheme in September 2018. It is a health premium program focused on affordable and better
North American Cardiovascular Devices Market Size, Share, Impressive Industry Gr …
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries. There are several cardiac health organizations working in the US, such as American Heart Association. The geriatric population is more
European Cardiovascular Devices Market: Analysis Report, Share, Trends and Overv …
European cardiovascular devices market is projected to grow at a significant CAGR of 3.5% during the forecast period. The rising geriatric population is raising prevalence of prevalence of CVD cases in the region. According to the European Commission, the share for the geriatric population has increased in 2008 and 2018. The proportion of working age population in the EU-28 is shrinking, whereas the number of those retired is expanding continuously.

All 5 Releases


More Releases for Europe

Synthetic Biology Market – Europe
Synthetic Biology Market Europe is expected to reach USD XX Billion by 2026 from USD XX Billion in 2016 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Synthetic biology has expanded into various interdisciplinary fields that may be defined as the combination of artificial design and engineering to produce biological systems, chemicals or living organisms. Synthetic biology is also used for improving applications
Europe Wooden Doors Market
Europe Wooden Doors Market https://www.qandqmarketresearch.com/reports/wooden-doors-market-78 This report studies the Wooden Doorsmarket status and outlook of Europe and major countries, from angles of players, countries, product types and end industries; this report analyzes the top players in Europe and major countries, and splits the Wooden Doors market by product type and applications/end industries. The global Wooden Doors market is valued at XX million USD in 2018 and is expected to reach XX million
Europe Radiotherapy Market
The Europe Radiotherapy Market research report consists of a primary and secondary research along with an in-depth analysis of the quantitative and qualitative aspects by the expert industry analysts and professionals, leading management bodies, to gain a profound insight of the industry as well as the industry performance. The Europe Radiotherapy Market report presents a lucid picture of the current industry landscape, including the historical and projected market size, based
Europe Business Assembly
The Europe Business Assembly (EBA) is an international corporation for the evolution and implementation of economic and social development. The company was established in April 2000 and its history shows a plethora of promising initiatives, creative growth and professional victories. EBA’s activity demonstrates the capabilities and power of professional partnership. The year 2000 saw the beginning and the foundation of EBA with the signing of the memorandum of cooperation and
Smartsourcing in Eastern Europe
In 2008 the outsourcing business of Eastern Europe was estimated at nearly $2 billion, representing just a tiny fraction of the global IT outsourcing market, estimated at about $386 billion. According to the Gartner Dataquest predictions, in the next four years Eastern Europe is expected to outstrip the rest of the offshore market concentrated mainly in the “classical” locations like India. By 2010 Eastern Europe’s IT outsourcing market share is
Home Control conquers Europe
European Home Control Summit attracts participation from leading International companies and organizations 29. February 2008 - Copenhagen/Frankfurt - The first European Wireless Home Control Summit on 9 April 2008, taking place parallel to Light + Building, features leading companies such as Merten, Horstmann, Danfoss, and market researcher Parks Associates as well as publicly funded organizations like the Danish Energy Saving Trust (DEST) presenting the newest trends, products and market strategies pertaining